US government warns on patient assistant program drug violations
This article was originally published in SRA
Executive Summary
In response to concerns in the US that some charities may be acting as conduits for drug makers to induce prescribing of their higher-priced medicines and other potential abuses involving patient assistant programs (PAPs), the Office of Inspector General for the Department of Health and Human Services has issued a supplemental advisory bulletin, which expands on its 2005 guidance document1-3.